OMB approves the
package for one year. Prior to re-submission for approval, FDA will
solicit comment on, evaluate, and report on the accuracy of their
burden estimates. Furthermore, if FDA receives any comments on this
submission, they are to immediately forward them to OMB.
Inventory as of this Action
Requested
Previously Approved
09/30/1996
09/30/1996
500
0
0
2,000
0
0
0
0
0
This regulation requires certain OTC
human drug and cosmetic products to be appropriately labeled
alerting customers to the tamper-resistant packaging.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.